Complete Response to Pembrolizumab in a Patient with Lynch Syndrome: A Case Report
Aref Chelal & Ashraf ALakkad · International Research Journal of Gastroenterology and Hepatology · 2022
Background: Lynch syndrome LS is a life-threatening condition caused by heterozygous mutations in mismatch repair genes (MMR). People with this syndrome are at increased risk of developing different types of cancers, such as colorectal carcinomas, endometrial cancer, and ovarian...
Open access
Research Article